|
HY-110374-50mg
|
MedChemexpress LLC
|
NVS-CECR2-1 [CAS 1992047-61-6]
|
|
Cancer-programmed cell death
|
|
|
HY-111614-100mg
|
MedChemexpress LLC
|
Melengestrol acetate [CAS 2919-66-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-112041-1mg
|
MedChemexpress LLC
|
Unesbulin [CAS 1610964-64-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-112041-10mg
|
MedChemexpress LLC
|
Unesbulin [CAS 1610964-64-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-112041-100mg
|
MedChemexpress LLC
|
Unesbulin [CAS 1610964-64-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-112041-25mg
|
MedChemexpress LLC
|
Unesbulin [CAS 1610964-64-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-112041-5mg
|
MedChemexpress LLC
|
Unesbulin [CAS 1610964-64-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-112041-50mg
|
MedChemexpress LLC
|
Unesbulin [CAS 1610964-64-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-112197-1mg
|
MedChemexpress LLC
|
PKG drug G1 [CAS 374703-78-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-112197-10mg
|
MedChemexpress LLC
|
PKG drug G1 [CAS 374703-78-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-112197-100mg
|
MedChemexpress LLC
|
PKG drug G1 [CAS 374703-78-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-112197-25mg
|
MedChemexpress LLC
|
PKG drug G1 [CAS 374703-78-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-112197-5mg
|
MedChemexpress LLC
|
PKG drug G1 [CAS 374703-78-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-112197-50mg
|
MedChemexpress LLC
|
PKG drug G1 [CAS 374703-78-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-112582-10mg
|
MedChemexpress LLC
|
N1-Methylpseudouridine [CAS 13860-38-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-112582-100mg
|
MedChemexpress LLC
|
N1-Methylpseudouridine [CAS 13860-38-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-112582-25mg
|
MedChemexpress LLC
|
N1-Methylpseudouridine [CAS 13860-38-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-112582-5mg
|
MedChemexpress LLC
|
N1-Methylpseudouridine [CAS 13860-38-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-112582-50mg
|
MedChemexpress LLC
|
N1-Methylpseudouridine [CAS 13860-38-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-113926-10mg
|
MedChemexpress LLC
|
BAY 60-2770 [CAS 1027642-43-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113926-100mg
|
MedChemexpress LLC
|
BAY 60-2770 [CAS 1027642-43-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113926-25mg
|
MedChemexpress LLC
|
BAY 60-2770 [CAS 1027642-43-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113926-5mg
|
MedChemexpress LLC
|
BAY 60-2770 [CAS 1027642-43-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113926-50mg
|
MedChemexpress LLC
|
BAY 60-2770 [CAS 1027642-43-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-114989-10mg
|
MedChemexpress LLC
|
Fluorizoline [CAS 1362243-70-6]
|
|
Cancer-programmed cell death
|
|
